{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:16:56Z","timestamp":1759940216776,"version":"3.37.0"},"reference-count":42,"publisher":"Rambam Health Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"DOI":"10.5041\/rmmj.10348","type":"journal-article","created":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T12:38:54Z","timestamp":1535891934000},"page":"e0032","source":"Crossref","is-referenced-by-count":10,"title":["Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents"],"prefix":"10.5041","volume":"9","author":[{"given":"Cecilia P.","family":"Labardini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eytan Z.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2983","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3928\/23258160-20140306-08","article-title":"Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"45","author":"Fileta","year":"2014","unstructured":"1. Fileta JB, Scott IU, Flynn HW Jr. Meta-analysis of infectious endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmic Surg Lasers Imaging Retina 2014;45: 143-9.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3928\/23258160-20151027-07","article-title":"Effect of a strict 'no-talking' policy during intravitreal injection on post-injection endophthalmitis","volume":"46","author":"Garg","year":"2015","unstructured":"2. Garg SJ, Dollin M, Hsu J, Storey P, Vander JF. Effect of a strict 'no-talking' policy during intravitreal injection on post-injection endophthalmitis. Ophthalmic Surg Lasers Imaging Retina 2015;46:1028-34.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/IAE.0b013e31821067c4","article-title":"Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center","volume":"31","author":"Moshfeghi","year":"2011","unstructured":"3. Moshfeghi AA, Rosenfeld PJ, Flynn HW Jr, et al. Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina 2011;31:662-8.","journal-title":"Retina"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/1469-0691.12118","article-title":"Endophthalmitis","volume":"19","author":"Durand","year":"2013","unstructured":"4. Durand ML. Endophthalmitis. Clin Microbiol Infect 2013;19:227-34.","journal-title":"Clin Microbiol Infect"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/archophthalmol.2010.19","article-title":"Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis","volume":"128","author":"Campbell","year":"2010","unstructured":"5. Campbell RJ, Bronskill SE, Bell CM, Paterson JM, Whitehead M, Gill SS. Rapid expansion of intravitreal drug injection procedures, 2000 to 2008: a population-based analysis. Arch Ophthalmol 2010; 128:359-62.","journal-title":"Arch Ophthalmol"},{"key":"ref5","unstructured":"6. Williams GA. IVT injections: health policy implica- tions. Review of Ophthalmology 2014; June. Available at: http:\/\/bit.ly\/2uo84kl (accessed July 2, 2018)."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1016\/j.ophtha.2011.02.034","article-title":"Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents","volume":"118","author":"CP","year":"2011","unstructured":"7. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA; Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology 2011;118:2028-34.","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/IAE.0b013e31820a67e4","article-title":"Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies","volume":"31","author":"McCannell","year":"2011","unstructured":"8. McCannell CA. Meta-analysis of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents: causative organisms and possible prevention strategies. Retina 2011;31:654-61.","journal-title":"Retina"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/pathogens7010009","article-title":"The pathogenesis of Staphylococcus aureus eye infections","volume":"7","author":"O'Callaghan","year":"2018","unstructured":"9. O'Callaghan RJ. The pathogenesis of Staphylococcus aureus eye infections. Pathogens 2018;7:9.","journal-title":"Pathogens"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Peyman GA, Bassili SS. A practical guideline for management of endophthalmitis. Ophthalmic Surg 1995;26:294-303.","DOI":"10.3928\/1542-8877-19950701-08"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"643","DOI":"10.3928\/23258160-20150610-08","article-title":"Current infectious endophthalmitis rates after intravitreal injections of anti-vascular endothelial growth factor agents and outcomes of treatment","volume":"46","author":"Gregori","year":"2015","unstructured":"11. Gregori NZ, Flynn HW, Schwartz SG, et al. Current infectious endophthalmitis rates after intravitreal injections of anti-vascular endothelial growth factor agents and outcomes of treatment. Ophthalmic Surg Lasers Imaging Retina 2015;46:643-8.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1136\/bjophthalmol-2011-301439","article-title":"Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes","volume":"96","author":"Simunovic","year":"2012","unstructured":"12. Simunovic MP, Rush RB, Hunyor AP, Chang AA. Endophthalmitis following intravitreal injection versus endophthalmitis following cataract surgery: clinical features, causative organisms and post-treatment outcomes. Br J Ophthalmol 2012;96:862-6.","journal-title":"Br J Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1097\/IAE.0b013e318221594a","article-title":"Endophthalmitis after intravitreal injection: the importance of viridans streptococci","volume":"31","author":"Chen","year":"2011","unstructured":"13. Chen E, Lin MY, Cox J, Brown DM. Endophthalmitis after intravitreal injection: the importance of viridans streptococci. Retina 2011;31:1525-33.","journal-title":"Retina"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/IAE.0000000000000694","article-title":"Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy","volume":"36","author":"Garg","year":"2016","unstructured":"14. Garg SJ, Dollin M, Storey P, et al. Microbial spectrum and outcomes of endophthalmitis after intravitreal injection versus pars plana vitrectomy. Retina 2016; 36:351-9.","journal-title":"Retina"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1001\/archophthalmol.2011.227","article-title":"Bacterial dispersal associated with speech in the setting of intravitreous injections","volume":"129","author":"Wen","year":"2011","unstructured":"15. Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol 2011; 129:1551-4.","journal-title":"Arch Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina 2012;32:473-6.","DOI":"10.1097\/IAE.0b013e31822c2958"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/IAE.0000000000000067","article-title":"Needle contamination in the setting of intravitreal injections","volume":"34","author":"Friedman","year":"2014","unstructured":"17. Friedman DA, Lindquist TP, Mason JO III, McGwin G. Needle contamination in the setting of intravitreal injections. Retina 2014;34:929-34.","journal-title":"Retina"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s00417-013-2274-y","article-title":"25% povidone-iodine irrigation and surgical mask","volume":"251","author":"Shimada","year":"2013","unstructured":"18. Shimada H, Hattori T, Mori R, Nakashizuka H, Fujita K, Yuzawa M. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask. Graefes Arch Clin Exp Ophthalmol 2013;251:1885-90.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/IAE.0000000000000071","article-title":"No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting","volume":"34","author":"Brynskov","year":"2014","unstructured":"19. Brynskov T, Kemp H, S\u00f8rensen TL. No cases of endophthalmitis after 20,293 intravitreal injections in an operating room setting. Retina 2014;34:951-7.","journal-title":"Retina"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.ophtha.2012.03.048","article-title":"Endophthalmitis is not a \"never event","volume":"119","author":"Schachat","year":"2012","unstructured":"20. Schachat AP, Rosenfeld PJ, Liesegang TJ, Stewart MW. Endophthalmitis is not a \"never event.\" Ophthalmology 2012;119:1507-8.","journal-title":"\" Ophthalmology"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Schimel AM, Scott IU, Flynn HW Jr. Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? Arch Ophthalmol 2011;129:1607-9.","DOI":"10.1001\/archophthalmol.2011.370"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1128\/am.16.2.428-429.1968","article-title":"Indigenous flora from human saliva","volume":"16","author":"DF","year":"1968","unstructured":"22. Gordon DF, Jong BB. Indigenous flora from human saliva. Appl Microbiol 1968;16:428-9.","journal-title":"Appl Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1046\/j.1365-2672.1998.00480.x","article-title":"The normal Lactobacillus flora of healthy human rectal and oral mucosa","volume":"85","author":"Ahrne","year":"1998","unstructured":"23. Ahrne S, Nobaek S, Jeppsson B, Adlerberth I, Wold AE, Molin G. The normal Lactobacillus flora of healthy human rectal and oral mucosa. J Appl Microbiol 1998;85:88-94.","journal-title":"J Appl Microbiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.ophtha.2009.02.024","article-title":"A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections","volume":"116","author":"Moss","year":"2009","unstructured":"24. Moss JM, Sanislo SR, Ta CN. A prospective randomized evaluation of topical gatifloxacin on conjunctival flora in patients undergoing intravitreal injections. Ophthalmology 2009;116:1498-501.","journal-title":"Ophthalmology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.ophtha.2012.01.016","article-title":"Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection","volume":"119","author":"Milder","year":"2012","unstructured":"25. Milder E, Vander J, Shah C, Garg S. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology 2012;119:1420-4.","journal-title":"Ophthalmology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1001\/jamaophthalmol.2013.2379","article-title":"Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection","volume":"131","author":"Yin","year":"2013","unstructured":"26. Yin VT, Weisbrod DJ, Eng KT, et al. Antibiotic resistance of ocular surface flora with repeated use of a topical antibiotic after intravitreal injection. JAMA Ophthalmol 2013;131:456-61.","journal-title":"JAMA Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.ophtha.2010.03.034","article-title":"Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections","volume":"117","author":"Kim","year":"2010","unstructured":"27. Kim SJ, Toma HS, Midha NK, Cherney EF, Recchia FM, Doherty TJ. Antibiotic resistance of conjunctiva and nasopharynx evaluation study: a prospective study of patients undergoing intravitreal injections. Ophthalmology 2010;117:2372-8.","journal-title":"Ophthalmology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.ajo.2014.06.019","article-title":"Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes","volume":"158","author":"Goldberg","year":"2014","unstructured":"28. Goldberg RA, Shah CP, Wiegand TW, Heier JS. Noninfectious inflammation after intravitreal injection of aflibercept: clinical characteristics and visual outcomes. Am J Ophthalmol 2014;158:733-7.","journal-title":"Am J Ophthalmol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Hahn P, Kim JE, Stinnett S, et al. Aflibercept-related sterile inflammation. Ophthalmology 2013;120:1100-101.e1-5.","DOI":"10.1016\/j.ophtha.2012.11.018"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3109\/08820538.2011.570847","article-title":"Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration","volume":"26","author":"Moshfeghi","year":"2011","unstructured":"30. Moshfeghi AA. Endophthalmitis following intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration. Semin Ophthalmol 2011;26:139-48.","journal-title":"Semin Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3928\/15428877-20110603-04","article-title":"Uveitis following intravitreal bevacizumab: a non-infectious cluster","volume":"42","author":"Kay","year":"2011","unstructured":"31. Kay CN, Tarantola RM, Gehrs KM, et al. Uveitis following intravitreal bevacizumab: a non-infectious cluster. Ophthalmic Surg Lasers Imaging 2011; 42:292-6.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"346","DOI":"10.3928\/15428877-20110210-02","article-title":"Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis","volume":"42","author":"Doshi","year":"2011","unstructured":"32. Doshi RR, Leng T, Fung AE. Povidone-iodine before lidocaine gel anesthesia achieves surface antisepsis. Ophthalmic Surg Lasers Imaging 2011;42:346-9.","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref32","unstructured":"33. Levinson J, Garfinkel R, Berinstein DM, Flory M, Spellman FA. Timing of povidone-iodine application to reduce the risk of endophthalmitis after intravitreal injections. Presented at American Society of Retina Specialists Annual Meeting, August 11-15, 2017, Boston, Massachusetts. Ophthalmol Retina 2017 August 31."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1001\/archophthalmol.2012.227","article-title":"Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics","volume":"130","author":"AR","year":"2012","unstructured":"34. Bhavsar AR, Stockdale CR, Ferris FL 3rd, Brucker AJ, Bressler NM, Glassman AR; Diabetic Retinopathy Clinical Research Network. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics. Arch Ophthalmol 2012;130:809-10.","journal-title":"Arch Ophthalmol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1001\/archophthalmol.2009.304","article-title":"Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinoloneclinical trials","volume":"127","author":"Bhavsar","year":"2009","unstructured":"35. Bhavsar AR, Googe JM Jr, Stockdale CR, et al. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinoloneclinical trials. Arch Ophthalmol 2009;127:1581-3.","journal-title":"Arch Ophthalmol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/j.ophtha.2012.02.014","article-title":"Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections","volume":"119","author":"Cheung","year":"2012","unstructured":"36. Cheung CS, Wong AW, Lui A, Kertes PJ, Devenyi RG, Lam WC. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections. Ophthalmology 2012;119:1609-14.","journal-title":"Ophthalmology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"18088","DOI":"10.1038\/s41598-017-18412-9","article-title":"Intravitreal injections of anti-VEGF agents and antibiotic prophylaxis for endophthalmitis: a systematic review and meta-analysis","volume":"7","author":"Bande","year":"2017","unstructured":"37. Bande MF, Mansilla R, Pata MP, et al. Intravitreal injections of anti-VEGF agents and antibiotic prophylaxis for endophthalmitis: a systematic review and meta-analysis. Sci Rep 2017;7:18088.","journal-title":"Sci Rep"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38. Menchini F, Toneatto G, Miele A, Donati S, Paolo L, Virgili G. Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review. Eye 2018 June 11. [Epub ahead of print].","DOI":"10.1038\/s41433-018-0138-8"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"39. Tanner J, Swarbrook S, Stuart J. Surgical hand antisepsis to reduce surgical site infection. Cochrane Database Syst Rev 2008;(1):CD004288.","DOI":"10.1002\/14651858.CD004288.pub2"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40942-015-0010-y","article-title":"Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review","volume":"1","author":"Merani","year":"2015","unstructured":"40. Merani R, Hunyor A. Endophthalmitis following intravitreal anti-vascular endothelial growth factor (VEGF) injection: a comprehensive review. Int J Retin Vitr 2015;1:9.","journal-title":"Int J Retin Vitr"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"35","DOI":"10.7748\/ns.23.6.35.s46","article-title":"Sterile versus non-sterile glove use and aseptic technique","volume":"23","author":"Flores","year":"2008","unstructured":"41. Flores A. Sterile versus non-sterile glove use and aseptic technique. Nurs Stand 2008;23:35-9.","journal-title":"Nurs Stand"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3928\/15428877-20120119-01","article-title":"Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection","volume":"43","author":"Lad","year":"2012","unstructured":"42. Lad EM, Maltenfort MG, Leng T. Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection. Ophthalmic Surg Lasers Imaging 2012;43:115-20.","journal-title":"Ophthalmic Surg Lasers Imaging"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/843\/1\/PublishFiles\/859Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T14:16:53Z","timestamp":1738851413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/39\/articles\/859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":42,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,10,4]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10348","relation":{},"ISSN":["2076-9172"],"issn-type":[{"type":"electronic","value":"2076-9172"}],"subject":[],"published":{"date-parts":[[2018,10,4]]}}}